Navigation Links
Pharmasset to Present at the Canaccord Adams Hepatitis C Conference on Wednesday, April 9th
Date:4/4/2008

PRINCETON, N.J., April 4, 2008 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) management will present at the Canaccord|Adams Hepatitis C Conference being held on April 9, 2008 at the St. Regis Hotel in New York, NY. Schaefer Price, Pharmasset's Chief Executive Officer, will provide an overview of the company's clinical and preclinical hepatitis C virus (HCV) programs at 11:15 AM (ET).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm . Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm .

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, fo
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmasset Receives $10 Million of Working Capital
2. Pharmasset Appoints Herbert J. Conrad as a Director
3. Pharmasset to Present at Cowen & Companys Health Care Conference on Tuesday, March 18th
4. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
5. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
6. Pharmasset Reports Fiscal Year End 2007 Financial Results
7. Pharmasset Appoints Michael Rogers as Chief Development Officer
8. Pharmasset to Present at Three Investor Conferences in November 2007
9. Pharmasset Accesses up to $30 Million of Working Capital
10. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
11. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... New York , July 31, 2014 ... by Transparency Market Research "Quantum Dots Market - Global ... - 2023," the market was valued at USD 88.5 ... 8,246.8 million by 2023, growing at a CAGR of ... full Quantum Dots Market Report at  http://www.transparencymarketresearch.com/quantum-dots.html ...
(Date:7/31/2014)... VALLEY, Calif. , July 31, 2014 ... San Francisco Bay Area , has acquired ... University of Oxford,s commercialisation company. The potent anti-inflammatory activity ... Greaves at the University of Oxford,s Sir ... The company, which has raised over $1.5 million in ...
(Date:7/31/2014)... NY (PRWEB) July 31, 2014 Graphite ... in high temperature oven carts. These bearings are uniquely ... in sealed ball bearings because of the high ... alumina requested help from the design engineers at Graphite ... a heating process. During their manufacturing operation, pans containing ...
(Date:7/31/2014)... York, NY (PRWEB) July 31, 2014 North ... New York City, partnered with GI Energy, one of the ... complete a $13 million upgrade of its 43-year-old CHP system. ... 1971 and in an effort to extend the life of ... six generators and associated electrical and heat recovery equipment, while ...
Breaking Biology Technology:Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 2Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 3Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 4Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2
... Findings Presented at American Academy of Pediatrics National Conference & ... ... and EAST NORRITON, Pa., Oct. 29 Tengion,Inc., a leader in ... today at the American Academy of,Pediatrics (AAP) National Conference and Exhibition ...
... 29 Cliniqa Corporation (San,Marcos, CA), a ... to,announce the acquisition of the primary assets ... a wholly owned subsidiary of Hemagen,Diagnostics, Inc. ... clinical,diagnostic products focusing on clinical chemistry reagents, ...
... American Society of Plastic Surgeons ... ... NBC,s,"Bionic Woman," the notion of a bionic person is thought of ... reality,as reconstructive plastic surgeons perform quality-of-life-enhancing,peripheral nerve surgeries once thought impossible. ...
Cached Biology Technology:Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 2Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 3Cliniqa Corporation Completes Asset Acquisition of Reagents Applications, Inc. 2Creating the Bionic Woman: Making Nerves Spring Back to Life 2Creating the Bionic Woman: Making Nerves Spring Back to Life 3
(Date:7/31/2014)... international team of scientists from Spain, France, and ... beetle that is the oldest definitive member of ... in amber. The discovery and description were made ... X-ray synchrotron imaging technique, which allows the detailed ... The new species is described in the journal ...
(Date:7/31/2014)... German . ... to a sponge that soaks up liquids. Hence, these ... greenhouse gases. However, loading of many MOFs is inhibited ... now report in Nature Communications that the ... This can be prevented by water-free synthesis and storing ...
(Date:7/31/2014)... An experimental vaccine protected 100 percent of animal models ... difficile , which causes an intestinal disease that kills ... of print in Infection and Immunity . ... and non-human primates against the purified toxins produced by ... orogastric spore infection, a laboratory model that mimics the ...
Breaking Biology News(10 mins):Free pores for molecule transport 2C. difficile vaccine proves safe, 100 percent effective in animal models 2
... locations with central nervous system infections may well be suffering ... a study to be published in mBio , the ... have detected the virus in spinal fluid from 4 percent ... cause, and in an average of 58 percent of fecal ...
... LOUIS -- In research published in Biochemical and ... a technology that can detect new, previously unknown viruses. ... viruses even when doctors have not identified a particular ... In the new approach, scientists use blood ...
... research associate has received a prestigious fellowship to support ... spread of malaria. Bart Bryant, research associate in ... Research Service Award Individual Postdoctoral Fellowship, which provides $113,000 ... University researcher to receive the award and is the ...
Cached Biology News:New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3NIH fellowship helps researcher fight malaria, understand mosquito immunity 2
... The AccuSpot automates LC microfractionaction, spotting ... With the AccuSpot system, LC eluent can ... plates, in trace amounts (eg.50nl). Matrix solutions ... automatic preparation of target plated for MALDI-TOF-MS ...
Glycerokinase; from Bacillus stearothermophilus...
PTFE/red rubber septum silver aluminum seal ,11 mm seal diam. ...
...
Biology Products: